COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

Autor:	Srikanth Muppidi, Jeffrey T Guptill, Saiju Jacob, Yingkai Li, Maria E Farrugia, Amanda C Guidon, Jinny O Tavee, Henry Kaminski, James F Howard, Gary Cutter, Heinz Wiendl, Matthew B Maas, Isabel Illa, Renato Mantegazza, Hiroyuki Murai, Kimiaki Utsugisawa, Richard J Nowak, Alok Tyagi, Ana Paula Sousa, Anthony A Amato, Ashwin Pinto, Bhaskar Roy, Caroline Carmichael, Dubravka Dodig, Georgina Burke, Gary R Cutter, Henry J Kaminski, Ikjae Lee, Jeffrey Guptill, James F. Howard, James Caress, Jane Pritchard, John Vissing, Kamla Best, Mahtab Ramezani, Mathew Maas, Michael K Hehir, Michelle Kaku, Natalia Jiménez Esquivel, Paul Gallagher, Paul Maddison, Philip A Ambrose, Renato E Mantegazza, Rocio Vazquez Do Campo, Sami Saba, Shahriar Nafissi, Shannon Itoyama, Stuart Viegas Viegas, Victoria Marshall, Yingkai Li Li
Rok vydání:	2020
Předmět:	2019-20 coronavirus outbreak Coronavirus disease 2019 (COVID-19) SARS-CoV-2 business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Clinical Neurology COVID-19 medicine.disease Virology Myasthenia gravis Risk Factors Correspondence Myasthenia Gravis medicine Humans Registries Neurology (clinical) business
Zdroj:	LANCET NEUROLOGY r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname The Lancet. Neurology The Lancet Neurology
ISSN:	1474-4422
DOI:	10.1016/s1474-4422(20)30413-0
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5728d2028ac5938c7dda87e81a9e0bc https://doi.org/10.1016/s1474-4422(20)30413-0 Zobrazit plný text záznamu